share_log

格隆汇公告精选(港股)︱洛阳钼业近日获得自然资源部颁发的三道庄钼矿采矿许可证

Selected Gelonghui Announcements (Hong Kong Stock) | Luoyang Molybdenum Industry recently obtained the Sandaozhuang Molybdenum Mine Mining License issued by the Ministry of Natural Resources

Gelonghui Finance ·  Nov 3, 2023 10:59

[Today's focus]

Luoyang Molybdenum Industry (03993.HK) recently obtained the Sandaozhuang Molybdenum Mine mining license issued by the Ministry of Natural Resources

Luoyang Molybdenum Industry (03993.HK) announced that Luoyang Luanchuan Molybdenum Industry Group Co., Ltd. (hereinafter referred to as the “Company”) recently obtained the Sandaozhuang Molybdenum Mine Mining License (certificate number: C1000002021113128000179) issued by the Ministry of Natural Resources. The mining rights change obtained this time is a continuation of the original mining license. Obtaining this mining license is conducive to further enhancing the company's ability to guarantee molybdenum and tungsten resources. Investors are kindly requested to pay attention to investment risks.

[Financial results]

Shenwei Pharmaceutical (02877.HK) had a turnover of 3.472 billion yuan in the first three quarters, up 21.9% year-on-year

The comprehensive net profit of China Heart to Heart Fertilizer (01866.HK) in the third quarter increased by about 35% year-on-year to 378 million yuan

Daming International (01090.HK)'s net profit for the first three quarters was about 16 million yuan, up about 116.2% year on year

Yidu (International Holdings) (00259.HK) expects medium-term owners to account for a profit of approximately HK$115 million

Baoguang Industrial (00084.HK) Profit Alert: Expected net loss of HK$20 million to HK$35 million in the medium term

Lee Kee (00637.HK) Profit Alert: Expected losses attributable to equity shareholders in the medium term are about HK$11.8 million to HK$17.7 million

Europeanization (01711.HK) Profit Warning: Expected net loss in the medium term is not more than HK$10 million

[Operational data]

Zhengrong Real Estate (06158.HK)'s cumulative contract sales amount for the first 10 months was about 13.776 billion yuan

Xuhui Holding Group (00884.HK)'s October contract sales amount is about 4.37 billion yuan

Agile Group (03383.HK): The total pre-sale amount in October was 3.48 billion yuan

Times China Holdings (01233.HK)'s October contract sales amount is about 750 million yuan

Yincheng International Holdings (01902.HK) had total contract sales of about 405 million yuan in October

Taiga Insurance (06161.HK) has obtained or is implementing service contracts with several Hong Kong and Chinese insurance intermediaries and financial services companies for a total amount exceeding HK$60 million

Swire Properties (01972.HK): Hong Kong's overall office occupancy rate fell to 93% in the third quarter

[Pharmaceutical Innovation]

Shiyao Pharmaceutical Group (01093.HK): Monoclonal antibody drug (SYS6011) approved for clinical trials

[Acquisition and sale]

Conch Venture (00586.HK) plans to acquire about 10.37% of Haichuang Green Energy's shares for 939 million yuan

Greenland Hong Kong (00337.HK) plans to acquire 30% of Guangzhou Green Port's shares for 120 million yuan

Big Health International (02211.HK) plans to sell 100% of Shenyang Weishi Pharmaceutical's shares for 40 million yuan

Global Credit Group (01669.HK) acquires nominee membership for HK$15 million

New Hope Services (03658.HK) subsidiary plans to acquire 80% of Chengdu Jinguan Xincheng Property Management's shares

Abel Technology (02708.HK): Chairman Lai Tze-ming's 760,000 company shares were forcibly sold

[Equity Incentives]

China Energy Storage Technology Development (01143.HK) granted a total of 15.6951 million share options

Jiumaojiu (09922.HK) granted a total of 7.054 million share options

Guichuang Tongqiao-B (02190.HK): Trustees repurchase 1,067 million shares under the 2021 H-share Reward Trust Plan

[Issuance of additional shares]

Lianhe Healthcare (00928.HK) plans to discount approximately 13.04% and place up to 308 million shares

Runge Interactive (02422.HK) plans to issue shares according to “2 for 1”

Zhongke Biotech (01237.HK) intends to consolidate shares according to “10 and 1”

[Increase or decrease holdings]

Yuanda Housing & Construction (02163.HK): Controlling shareholder Zhang Jian has increased his H share holdings of the company by 10.14 million shares

Yadi Holdings (01585.HK) received a total increase of 148,000 shares from controlling shareholders

[Repurchase Cancellation]

HSBC Holdings (00005.HK) spent HK$142 million to repurchase 2,498,000 shares

Standard Chartered Group (02888.HK) spent £17.9777 million to repurchase 2,8937 million shares on November 2

AIA (01299.HK) spent HK$135 million to repurchase 1,9094 million shares on November 3

Shell-W (02423.HK) spent $7.4383 million to repurchase 1.5 million shares on November 2

Orient Securities (03958.HK) spent 29.5333,300 yuan to repurchase 3.304,900 A-shares on November 3

ESR (01821.HK) spent HK$12.33 million to repurchase 1.2 million shares on November 3

Dongfeng Group Shares (00489.HK) spent HK$12.643,600 to repurchase 3,584,000 shares on November 3

Haier Smart Home (06690.HK) spent 1.06 million yuan to repurchase 490,000 A-shares on November 3

Yum China (09987.HK) spent 1.5 million US dollars to repurchase 33,000 shares on November 2

China Petroleum & Chemical Co., Ltd. (00386.HK) spent HK$10.7775 million to repurchase 2.63 million shares on November 3

COSCO Marine Control (01919.HK) spent HK$9.56 million to repurchase 1.198,000 shares on November 3

Haohai Biotechnology (06826.HK) spent HK$6.120,500 to repurchase 142,400 shares on November 3

Shanghai Petrochemical Co., Ltd. (00338.HK) spent HK$3,504,400 to repurchase 2,826 million shares on November 3

Zhongyu Energy (03633.HK) spent HK$2.75 million to repurchase 500,000 shares on November 3

Yuanzheng Technology (02488.HK) spent HK$1.99 million to repurchase 958,500 shares on November 2

Greentown Services (02869.HK) spent HK$1,913,300 to repurchase 600,000 shares on November 3

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment